Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04678440 · ClinicalTrials.gov registry record · Early Phase 1
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
A Early Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT04678440 is a Early Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 5 participants.
The verdict
NCT04678440, a Early Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
In this pilot study, healthy volunteers and patients with Non-Small Cell Lung Cancer will undergo \[18F\]F-AraG dynamic imaging on the uEXPLORER total body Positron Emission Tomography/Computerized Tomography scanner to obtain preliminary data regarding pharmacokinetics and early biodistribution images.
Interventions
- DRUG [18F]F-AraG Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2023-02-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04678440
The ClinicalTrials.gov registry entry for NCT04678440 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]F-AraG Imaging is the first listed.
NCT04678440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04678440 about?
NCT04678440 is a clinical study titled "[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients". In this pilot study, healthy volunteers and patients with Non-Small Cell Lung Cancer will undergo \[18F\]F-AraG dynamic imaging on the uEXPLORER total body Positron Emission Tomography/Computerized Tomography scanner to obtain preliminary data regarding pharmacokinetics and early biodistribution ima...
What is the current status of trial NCT04678440?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2021-03-31. Estimated completion is 2023-02-07.
What interventions are being tested in trial NCT04678440?
The interventions under investigation include: [18F]F-AraG Imaging (DRUG).
Who is sponsoring clinical trial NCT04678440?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.